Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases

被引：13

作者：

Habe, Koji ^{[1
]}

Wada, Hideo ^{[2
]}

Matsumoto, Takeshi ^{[3
]}

Ohishi, Kohshi ^{[3
]}

Ikejiri, Makoto ^{[2
]}

Matsubara, Kimiko ^{[1
]}

Morioka, Tatsuhiko ^{[1
]}

Kamimoto, Yuki ^{[4
]}

Ikeda, Tomoaki ^{[4
]}

Katayama, Naoyuki ^{[5
]}

Nobori, Tsutomu ^{[2
]}

Mizutani, Hitoshi ^{[1
]}

机构：

[1] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 5148507, Japan

[2] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan

[3] Mie Univ, Grad Sch Med, Dept Blood Transfus, Tsu, Mie 5148507, Japan

[4] Mie Univ, Grad Sch Med, Dept Obstet & Gynecol, Tsu, Mie 5148507, Japan

[5] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2013年 / 97卷 / 03期

基金：

日本学术振兴会;

关键词：

APS; Thrombosis; aPL; LA; beta 2-Glycoprotein I; SYSTEMIC-LUPUS-ERYTHEMATOSUS; THROMBOCYTOPENIC PURPURA; ANTICOAGULANT LA; PREVALENCE; GUIDELINES; MANAGEMENT; DIAGNOSIS;

D O I：

10.1007/s12185-013-1277-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiphospholipid antibodies (aPL) including lupus anticoagulant (LA), anticardiolipin antibodies (aCL) IgG and aCL-beta 2-glycoprotein I (beta 2GPI) complex IG are causative factors for thrombotic event (THE). We retrospectively investigated relationships between aPLs and THE in 458 patients suspected of having antiphospholipid syndrome. THEs were observed in 232 of 458 patients, including 148 cases of venous thrombosis, 59 of arterial thrombosis, 18 of microthrombosis, and 20 of complications of pregnancy. The frequency of THE was significantly high in patients positive for LA and/or aPL. In patients with autoimmune disease (AID), the frequency of THE was significantly high in patients with any types of aPLs. Additionally, risk of THE was significantly increased in patients with more than two types of aPLs. Prolonged activated partial thromboplastin time indicated a high risk for THE. However, neither thrombocytopenia nor AID was a risk for THE. In conclusion, the presence of aPL is an indicator for high risk of THE in patients in whom THE was suspected. However, the risk of THE in aPL-positive patients varied among patients with different underlying diseases.

引用

页码：345 / 350

页数：6

共 50 条

[31] Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies [J].

Wolfgang Miesbach ;

Inge Scharrer ;

Ronald Asherson .

Clinical Rheumatology, 2006, 25 :840-844

[32] Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies [J].

Miesbach, Wolfgang ;

Scharrer, Inge ;

Asherson, Ronald .

CLINICAL RHEUMATOLOGY, 2006, 25 (06) :840-844

[33] Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome? [J].

Yelnik, Cecile Marie ;

Dubucquoi, Sylvain ;

Houfflin-Debarge, Veronique ;

Lambert, Marc .

PRESSE MEDICALE, 2015, 44 (03) :284-291

[34] Clinical Management of Thrombotic Antiphospholipid Syndrome [J].

Tumian, Nor Rafeah ;

Hunt, Beverley J. .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)

[35] Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases [J].

Flavio Signorelli ;

Felipe Nogueira ;

Vinicius Domingues ;

Henrique Ataide Mariz ;

Roger A. Levy .

Clinical Rheumatology, 2016, 35 :801-805

[36] Risk factors for thrombotic events in systemic lupus erythematosus patients with antiphospholipid antibodies: insights from morphometric measurements of carotid arteries [J].

Yang, Qing ;

Liu, Qi ;

Yin, Changqing ;

Zhang, Xiaoyu ;

Chen, Xi ;

Pylypenko, Dmytro ;

Chen, Hao ;

Shu, Qiang ;

Yu, Dexin .

FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11

[37] Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience [J].

Abu-Zeinah, Ghaith ;

Oromendia, Clara ;

DeSancho, Maria T. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) :233-239

[38] Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience [J].

Ghaith Abu-Zeinah ;

Clara Oromendia ;

Maria T. DeSancho .

Journal of Thrombosis and Thrombolysis, 2019, 48 :233-239

[39] Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence [J].

Pengo, Vittorio ;

Sarti, Luca ;

Antonucci, Emilia ;

Bison, Elisa ;

Pontara, Elena ;

Cattini, Maria Grazia ;

Denas, Gentian ;

Poli, Daniela ;

Palareti, Gualtiero .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (09) :1870-1876

[40] Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome [J].

del-Pino, Rodrigo Aguirre ;

Monahan, Rory C. ;

Huizinga, Tom W. J. ;

Eikenboom, Jeroen ;

Steup-Beekman, Gerda M. .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06) :817-828

← 1 2 3 4 5 →